The groundbreaking treatment of this peptide represents a major advance in the care of type 2 diabetes. Different to existing medications, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide186358.ivasdesign.com/63182053/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment